VDAC3 and neurodegenerative disease: The same approach was previously used by our group for the characterization of human VDAC3 20 and its cysteine mutants 21, and for the production of human VDAC1 suitable for interaction studies with proteins involved in neurodegenerative diseases 22, 30.